NCM
HOOK

Nantahala Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Nantahala Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,357
Closed -$1.1M – 129
2021
Q4 		$1.1M Sell
47,357
-2,182
-4% -$87.7K 0.04% 118
2021
Q3 		$2.92M Sell
49,539
-1,672
-3% -$121K 0.09% 95
2021
Q2 		$4.69M Sell
51,211
-38,789
-43% -$5.17M 0.13% 92
2021
Q1 		$12.1M Buy
+90,000
New +$10.9M 0.35% 58

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nantahala Capital Management's HOOK Position: Q1 2022 in Review

Nantahala Capital Management sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 47,357 shares — an estimated $1.1M sold.

Nantahala Capital Management first reported a position in HOOK in Q1 2021 and held it in 4 quarters. The position peaked at $12.1M in Q1 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

  • Nantahala Capital Management reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
  • Nantahala Capital Management sold 47,357 HOOKIPA Pharma shares in Q1 2022, an estimated $1.1M.
  • Nantahala Capital Management first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 4 quarters.
  • Nantahala Capital Management's HOOKIPA Pharma position peaked at $12.1M in Q1 2021.
  • 74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Nantahala Capital Management's 13F filing for Q1 2022, filed 13 May 2022.